Several outlets report growing public interest in blood tests that claim to detect microplastics in the body, alongside criticism from some experts who describe such testing as largely “useless.” The reports focus on the idea that people are widely exposed to microplastics through inhalation, food and drink.
The articles say scientists and health professionals raise concerns about what a positive blood test can actually tell a patient. They question whether current tests reliably measure clinically meaningful exposure or health effects, and note that microplastics are difficult to assess in a way that clearly links results to specific outcomes. Some sources also highlight that microplastics research is still evolving, and that evidence tying bloodstream findings to disease risk is limited.
Across the outlets, the shared angle is scepticism about the health value of commercial-style blood testing, even as all acknowledge that exposure from multiple environmental pathways is a real and ongoing issue. The differing emphasis is mainly on the framing—some lead with the promise of testing, others foreground expert criticism—while maintaining the same overall message: the presence and measurement of microplastics in blood is not yet established as a practical tool for health decisions.
